Scot Remick, MD

Scot Remick, MD

Oncology Morgantown, WV

Cancer Center Director at Mary Babb Randolph Cancer Center at West Virginia University


Office Address

  • 1 Medical Center Drive
    Morgantown, WV 26506
    Phone: (304) 598-4800

Scot Remick, MD

Oncology Morgantown, WV

Cancer Center Director at Mary Babb Randolph Cancer Center at West Virginia University

Clinical Specialties & Interests

  • Oncology: General Oncology
  • Clinical Interests: Cardiovascular; International health; Pharmacology; Child development; Thyroid; AIDS malignancies/international training cancer; cancer trials; developmental therapeutics; and cardiovascular complications of novel agents; anaplastic thyroid cancer and malignant melanoma.

Education & Medical Training

  • Johns Hopkins UniversityJohns Hopkins University
  • New York Medical CollegeNew York Medical College
  • University of WisconsinUniversity of Wisconsin

Certifications & Licensure

  • WV State Medical LicenseWV State Medical License2007 - 2015
  • American Board of Internal MedicineInternal Medicine, 1985
  • American Board of Internal MedicineMedical Oncology, 1987

Awards, Honors, & Recognition

  • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009
  • America's Top Doctors for CancerCastle Connolly, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005
  • CMS Meaningful Use Stage 1 CertificationEpicCare Ambulatory EMR, Epic Systems Corporation, 2012, 2013

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Developing Research Capacity For AIDS Malignancy In KenyaNational Cancer Institute
    2010 - 2011
  • Epothilone B Analogue BMS-247550 In PTS With Malignancies &Liver DysfunctionNational Center For Research Resources
    2006 - 2006
  • Foreign Accrual For 5u10ca062502 - Phase I U01 2006 Load RemickNational Cancer Institute
    2006 - 2006
  • 17-Allylamino-17 Demethoxygeldanamycin (17-Aag) W/Paclitaxel In Adv Solid TumorsNational Center For Research Resources
    2006 - 2006
  • 17-Dimethylaminoethylamino-17demethoxygeldanamycin In Advanced Solid TumorsNational Center For Research Resources
    2005 - 2006
  • Bryostatin 1 + Vincristine In Non-Hodgkin'S Lymphoma Post TransplantNational Center For Research Resources
    2005 - 2006
  • Combretastatin A-4 Phosphate In Advanced Anaplastic Thyroid CarcinomaNational Center For Research Resources
    2005 - 2006
  • Combretastatin/Doxorubicin/Cisplatin For Patients With Thyroid CancerNational Center For Research Resources
    2005 - 2006
  • STI571 In Adv Malignancies Amp;Varying Degrees Of Renal DysfunctionNational Center For Research Resources
    2005 - 2005
  • Silicone Phthalocyanine 4 (PC4) Photodynamic Therapy For Cutaneous MalignanciesNational Center For Research Resources
    2005 - 2005
  • Fenretinide + Paclitaxel + Cisplatin For Advanced Solid TumorsNational Center For Research Resources
    2005 - 2005
  • Epothilone B Analogue BMS-247550 In PTS With Malignancies And Liver DysfunctionNational Center For Research Resources
    2005 - 2005
  • STI571 In PTS With Advanced Malignancies &Varying Levels Of Liver DysfunctionNational Center For Research Resources
    2004 - 2004
  • Combretastatin A-4 Phosphate In Advanced Anaplastic Carcinoma Of The ThyroidNational Center For Research Resources
    2004 - 2004
  • Oxaliplatin, Irinotecan, And Capecitabine In Solid TumorsNational Center For Research Resources
    2004 - 2004
  • Silicon Phthalocyanine 4 (PC4) + Photodynamic Therapy For Cutaneous MalignanciesNational Center For Research Resources
    2004 - 2004
  • STI571 In PTS With Advanced Malignancies &Varying Degrees Of Renal DysfunctionNational Center For Research Resources
    2004 - 2004
  • Thalidomide And Docetaxel For Advanced MalignanciesNational Center For Research Resources
    2004 - 2005
  • SU5416 And Paclitaxel In Recurrent Or Metastatic Carcinoma Of The Head And NeckNational Center For Research Resources
    2004 - 2004
  • PS-341 In Patients With Advanced Malignancies And Renal DysfunctionNational Center For Research Resources
    2004 - 2006
  • Bryostatin 1+Vincristine In Non-Hodgkin'S Lymphoma PTS Post TransplantationNational Center For Research Resources
    2004 - 2004
  • Oral Chemotherapy In Aids-Related NHL In Uganda &KenyaNational Cancer Institute
    2002 - 2003
  • Oral Chemotherapy In AIDS Related NHL In Uganda &KenyaNational Cancer Institute
    2001 - 2001
  • Oxi 104 In Combination W/ Cisplatin In Patients W/ Advanced CancerNational Center For Research Resources
    1999 - 2002
  • CCM AIDS Associated Malignancies Clinical Trials UnitNational Cancer Institute
    1999 - 2005
  • Bryostatin 1 &Vincristine In B Cell MalignanciesNational Center For Research Resources
    1999 - 2002
  • CA4P (INTRAVENOUS) In Patients W/ Advanced CancerNational Center For Research Resources
    1999 - 2002
  • Cwru/Uhicc Phase I Trials Of Anticancer AgentsNational Cancer Institute
    1998 - 2006
  • Core--InternationalNational Institute Of Allergy And Infectious Diseases
    1998 - 2002
  • Rebeccamycin Analog Given 5 Consecutive Days In Patients With Solid TumorsNational Center For Research Resources
    1998 - 2002
  • Core--Clinical Trials Support FacilityNational Cancer Institute
    1996 - 2000
  • Cooperative Oncology GroupNational Cancer Institute
    1994 - 1994
  • Aids-Related CNS LymphomaNational Cancer Institute
    1993 - 1994
  • Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    1993 - 1996
  • Eastern Cooperative Oncology GroupNational Cancer Institute
    1992 - 1993

Professional Memberships"

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • Coventry Carelink Health Plans PPO
  • First Health PPO
  • Great West PPO
  • Health Net HMO - Employer Group
  • HealthAmerica HealthAssurance PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • The full profile is locked and available to verified physicians only.
    Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

Physicians, view Dr. Remick's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV

© 2015 Doximity, Inc.HelpBlogCompanyContactPrivacyDirectory